Biotechnology major Biocon's research arm Syngene International's initial public offering was over-subscribed on the second day of the offer on Tuesday.
first published: Jul 28, 2015 10:17 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

